Skip to content
Screener

MapLight Therapeutics, Inc. MPLT Accretion (Amortization) of Discounts and Premiums, Investments

Accretion (Amortization) of Discounts and Premiums, Investments at other companies

Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$50K-96.7%
LBR
LB Pharmaceuticals IncLBRX
-$17K-242%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$364K-16.5%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$689K-30.2%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$551.86M-20.5%
Enterprise value$501.74M

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio22.9×

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.

The source filing: MapLight Therapeutics, Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:25 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-224129
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation162166
Stock-based compensation expense9,636212
Net amortization of premiums and accretion of discounts on investments(814)(257)
Non-cash lease expense229212
Loss on disposal of property and equipment4
Changes in operating assets and liabilities:
Prepaid expenses and other assets2,475(193)

Item 1. Financial Statements.

FAQ

What is MapLight Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
MapLight Therapeutics, Inc. (MPLT) reported accretion (amortization) of discounts and premiums, investments of $814K in Q1 2026.
What does accretion (amortization) of discounts and premiums, investments mean?
This represents the non-cash adjustment to net income resulting from the amortization of premiums or accretion of discounts on debt securities held as investments. It reflects the gradual adjustment of the carrying value of investment assets toward their face value over time. This metric is essential for reconciling net income with actual cash flows generated from investment activities.

Ask your AI about MapLight Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude